Types of laxatives

Laxatives are medicines that relieve constipation (difficulty with bowel movements). They are a popular type of over-the-counter remedy. They can also be prescribed for conditions that could get wor...

The Top 100 Pharmaceutical Companies

The Top 100 Pharmaceutical Companies, determined by total sales in 2011 - see below for 2010 and  2009: They are listed in descending order with the sales in 2011 in $ million; Pfizer ...

Perrigo net sales increase 18% to $920M in third quarter 2013

Perrigo Company today announced results for its third quarter ended March 30, 2013.Perrigo's Chairman and CEO Joseph C. Papa commented, "We are very pleased with our performance, as the team delivered...

Cadence and Perrigo settle patent dispute

Cadence Pharmaceuticals Inc. said Wednesday that it settled a patent dispute with Perrigo Co. on its only marketed drug, the fever and pain treatment Ofirmev.Under the settlement Perrigo Co. can star...

Analyst upgrades Perrigo on Sergeant's acquisition

An analyst boosted Perrigo's rating and price target on Friday after the company said it is buying animal healthcare company Sergeant's Pet Care Products Inc. for $285 million.Late Thursday, Perrigo...

Par Pharmaceutical Receives Final Approval To Market Tretinoin Capsules

WOODCLIFF LAKE, N.J., Oct. 25, 2012 /PRNewswire/ -- Par Pharmaceutical Companies, Inc. today announced that its operating subsidiary, Anchen Pharmaceuticals, Inc., has received final approval fro...

Perrigo Company übertrifft Gewinnerwartungen

Allegan (BoerseGo.de) - Der US-Pharmakonzern Perrigo Company mit Sitz in Allegan (Bundesstaat Michigan) hat im zweiten Quartal des Geschäftsjahres 2012/13 einen Umsatz von 883 Millionen US-Dollar e.....

Perrigo Receives FDA Approval And Commences Launch Of Clobetasol Propionate Shampoo, 0.05%

ALLEGAN, Mich., Aug. 9, 2012 /- Perrigo Company (Nasdaq: PRGO;TASE) today announced that it has received final approval from the U.S. Food and Drug Administration for its abbreviated new drug app...

Perrigo Company Announces Quarterly Dividend

ALLEGAN, Mich., May 2, 2013 /PRNewswire/ -- Perrigo Company (Nasdaq: PRGO;TASE) today announced that its Board of Directors declared a quarterly dividend of $0.09 per share, payable on June 18, 2...

Perrigo-Aktie: Pharmakonzern gibt Zukauf bekannt

Allegan - Der amerikanische Pharmahersteller Perrigo Co. (ISIN US7142901039/ WKN 883878) hat sein Produktsortiment durch einen Zukauf erweitert. Wie aus einer am Donnerstag veröffentlichten Pressem.....

Safety and efficacy evaluation of tretinoin cream 0.02% for the reduction of photodamage: a pilot study.

Background: Clinical studies as well as histologic data maintain that tretinoin improves the appearance of photodamage; however, the long-term benefits of tretinoin 0.02% in moderate to severe photoda...

A Randomized, Double-Blind, Controlled Comparative Trial of the Anti-Aging Properties of Non-Prescription Tri-Retinol 1.1% vs. Prescription Tretinoin 0.025%.

Vitamin A and its derivatives (commonly termed retinoids) are widely used in topical anti-aging products. Certain retinoids such as retinol and its esters are available without a prescription, while o...

Cortexolone 17α-propionate 1% cream, a new potent anti-androgen for topical treatment of acne vulgaris. A pilot randomized, double-blind comparative study versus placebo and tretinoin (Retin-A(®) 0.05% cream).

Background:  Acne vulgaris is a disorder of the pilo-sebaceous unit in which the androgens contribute to its onset and persistence. The use of anti-androgens is therefore potentially effective, howe...

Further enhancement of facial appearance with a hydroquinone skin care system plus tretinoin in patients previously treated with botulinum toxin type a.

Background: A hydroquinone (HQ) skin care system has been designed for use in conjunction with nonsurgical procedures. Objective: The authors evaluate the efficacy of this system plus tretinoin for im...

Tretinoin and the Prevention of Keratinocyte Carcinoma (Basal and Squamous Cell Carcinoma of the Skin): A Veterans Affairs Randomized Chemoprevention Trial.

Keratinocyte carcinoma (KC) is the most common cancer in the United States, with no proven means for prevention other than systemic retinoids, which have significant toxicity, and sunscreen. Topical t...